New way to assess pace of aging could accelerate anti-aging breakthroughs

Researchers have identified twelve candidate indicators based on mouse studies that could revolutionize how scientists measure aging and develop anti-aging treatments. These biomarkers offer a faster, more objective way to assess whether interventions are slowing the aging process, potentially reducing the time and cost of clinical trials. By providing new insights into age-related diseases like Alzheimer's and heart disease, this approach could help develop therapies that address the underlying causes of aging rather than just treating symptoms. The findings represent a significant step toward personalized medicine and could eventually enable doctors to monitor aging at the individual level.